| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6760790
[patent_doc_number] => 20030124151
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Pamidronate solution'
[patent_app_type] => new
[patent_app_number] => 10/359471
[patent_app_country] => US
[patent_app_date] => 2002-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2027
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 81
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0124/20030124151.pdf
[firstpage_image] =>[orig_patent_app_number] => 10359471
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/359471 | Pamidronate solution | Nov 5, 2002 | Abandoned |
Array
(
[id] => 6761985
[patent_doc_number] => 20030125347
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-03
[patent_title] => 'Pharmaceutical composition'
[patent_app_type] => new
[patent_app_number] => 10/288262
[patent_app_country] => US
[patent_app_date] => 2002-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5225
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0125/20030125347.pdf
[firstpage_image] =>[orig_patent_app_number] => 10288262
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/288262 | Pharmaceutical composition | Nov 3, 2002 | Abandoned |
Array
(
[id] => 6779258
[patent_doc_number] => 20030050340
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-13
[patent_title] => 'Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption'
[patent_app_type] => new
[patent_app_number] => 10/279598
[patent_app_country] => US
[patent_app_date] => 2002-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2457
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0050/20030050340.pdf
[firstpage_image] =>[orig_patent_app_number] => 10279598
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/279598 | Encapsulated calcium acetate caplet and a method for inhibiting gastrointestinal phosphorous absorption | Oct 23, 2002 | Issued |
Array
(
[id] => 6860621
[patent_doc_number] => 20030091629
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Sublingual buccal effervescent'
[patent_app_type] => new
[patent_app_number] => 10/269669
[patent_app_country] => US
[patent_app_date] => 2002-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3023
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 129
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20030091629.pdf
[firstpage_image] =>[orig_patent_app_number] => 10269669
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/269669 | Sublingual buccal effervescent | Oct 10, 2002 | Abandoned |
Array
(
[id] => 6791621
[patent_doc_number] => 20030086965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-08
[patent_title] => 'Combination chemotherapy'
[patent_app_type] => new
[patent_app_number] => 10/185221
[patent_app_country] => US
[patent_app_date] => 2002-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7754
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20030086965.pdf
[firstpage_image] =>[orig_patent_app_number] => 10185221
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/185221 | Combination chemotherapy | Oct 8, 2002 | Abandoned |
Array
(
[id] => 6710551
[patent_doc_number] => 20030170300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-11
[patent_title] => 'Combination chemotherapy'
[patent_app_type] => new
[patent_app_number] => 10/184309
[patent_app_country] => US
[patent_app_date] => 2002-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7751
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0170/20030170300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10184309
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/184309 | Combination chemotherapy | Oct 7, 2002 | Abandoned |
Array
(
[id] => 6647392
[patent_doc_number] => 20030075817
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-24
[patent_title] => 'Process for producing microsphere'
[patent_app_type] => new
[patent_app_number] => 10/257024
[patent_app_country] => US
[patent_app_date] => 2002-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 8906
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0075/20030075817.pdf
[firstpage_image] =>[orig_patent_app_number] => 10257024
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/257024 | Process for producing microsphere | Oct 7, 2002 | Abandoned |
Array
(
[id] => 6855742
[patent_doc_number] => 20030129243
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-07-10
[patent_title] => 'Compositions comprising nucleic acids incorporated in bilaminar mineral particles'
[patent_app_type] => new
[patent_app_number] => 10/169392
[patent_app_country] => US
[patent_app_date] => 2002-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5803
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 17
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20030129243.pdf
[firstpage_image] =>[orig_patent_app_number] => 10169392
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/169392 | Compositions comprising nucleic acids incorporated in bilaminar mineral particles | Oct 2, 2002 | Abandoned |
Array
(
[id] => 6813248
[patent_doc_number] => 20030072798
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof'
[patent_app_type] => new
[patent_app_number] => 10/252158
[patent_app_country] => US
[patent_app_date] => 2002-09-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5525
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0072/20030072798.pdf
[firstpage_image] =>[orig_patent_app_number] => 10252158
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/252158 | Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof | Sep 22, 2002 | Abandoned |
Array
(
[id] => 1014309
[patent_doc_number] => 06893649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-17
[patent_title] => 'Solid powder cosmetics'
[patent_app_type] => utility
[patent_app_number] => 10/237091
[patent_app_country] => US
[patent_app_date] => 2002-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8800
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/893/06893649.pdf
[firstpage_image] =>[orig_patent_app_number] => 10237091
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/237091 | Solid powder cosmetics | Sep 8, 2002 | Issued |
| 10/111876 | Swellable delivery system | Aug 8, 2002 | Abandoned |
Array
(
[id] => 6842610
[patent_doc_number] => 20030147957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-07
[patent_title] => 'Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release core'
[patent_app_type] => new
[patent_app_number] => 10/195036
[patent_app_country] => US
[patent_app_date] => 2002-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9348
[patent_no_of_claims] => 58
[patent_no_of_ind_claims] => 18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0147/20030147957.pdf
[firstpage_image] =>[orig_patent_app_number] => 10195036
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/195036 | Dual release formulation comprising levodopa ethyl ester and a decarboxylase inhibitor in immediate release layer with levodopa ethyl ester and a decarboxylase inhibitor in a controlled release core | Jul 11, 2002 | Abandoned |
| 10/110440 | Compositions and methods for inhibiting islet dysfunction and autoimmune disorders | Jul 7, 2002 | Abandoned |
Array
(
[id] => 6643431
[patent_doc_number] => 20030104048
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-06-05
[patent_title] => 'Pharmaceutical dosage forms for highly hydrophilic materials'
[patent_app_type] => new
[patent_app_number] => 10/158206
[patent_app_country] => US
[patent_app_date] => 2002-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 21559
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20030104048.pdf
[firstpage_image] =>[orig_patent_app_number] => 10158206
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/158206 | Pharmaceutical dosage forms for highly hydrophilic materials | May 28, 2002 | Abandoned |
Array
(
[id] => 6535260
[patent_doc_number] => 20020193251
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Synergistic mixtures of selected amino acids'
[patent_app_type] => new
[patent_app_number] => 10/146037
[patent_app_country] => US
[patent_app_date] => 2002-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2098
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20020193251.pdf
[firstpage_image] =>[orig_patent_app_number] => 10146037
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/146037 | Synergistic mixtures of selected amino acids | May 15, 2002 | Abandoned |
| 10/009314 | Release of poorly soluble agents | Mar 31, 2002 | Abandoned |
| 10/019464 | Medical fabric with virucidal and antimicrobial action and articles therefrom | Mar 31, 2002 | Abandoned |
Array
(
[id] => 6829300
[patent_doc_number] => 20030180358
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-09-25
[patent_title] => 'System and method for affecting the pH state of the contents of the distal bowel in mammals'
[patent_app_type] => new
[patent_app_number] => 10/105712
[patent_app_country] => US
[patent_app_date] => 2002-03-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 818
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0180/20030180358.pdf
[firstpage_image] =>[orig_patent_app_number] => 10105712
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/105712 | System and method for affecting the pH state of the contents of the distal bowel in mammals | Mar 24, 2002 | Abandoned |
Array
(
[id] => 5967399
[patent_doc_number] => 20020090390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-11
[patent_title] => 'Device and method for treating urinary incontinence in females'
[patent_app_type] => new
[patent_app_number] => 10/096990
[patent_app_country] => US
[patent_app_date] => 2002-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 15621
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0090/20020090390.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096990
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096990 | Device and method for treating urinary incontinence in females | Mar 12, 2002 | Abandoned |
Array
(
[id] => 6530350
[patent_doc_number] => 20020136744
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-09-26
[patent_title] => 'Sustained release drug dispersion delivery device'
[patent_app_type] => new
[patent_app_number] => 10/096212
[patent_app_country] => US
[patent_app_date] => 2002-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11156
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0136/20020136744.pdf
[firstpage_image] =>[orig_patent_app_number] => 10096212
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/096212 | Sustained release drug dispersion delivery device | Mar 11, 2002 | Abandoned |